Site navigation
Our sites
Hepatitis B vaccination within the first 24 hours has been part of Australia’s National Immunisation Program for 25 years, helping to reduce hepatitis B in the Australian population.
Hepatitis B is Australia’s most prevalent blood-borne virus, with nearly 220,000 people estimated to be living with chronic infection. In a recent report called ‘If Hepatitis was 100 People’, Hepatitis …
The Australian Government is funding a new hepatitis C awareness campaign to be piloted in Tasmania, as part of national efforts to identify and treat people who may be living with the …
Fighting two infections at once puts an extra-heavy burden on the immune system. In Australia for example, a number of older people with haemophilia live with both hepatitis C and …
Hepatitis is not often seen as a health issue for children – but as shown in Community News #107, children can be at risk of hepatitis or hepatitis-related health issues …
Australia’s hepatitis experts have welcomed a new statement from the Australian Technical Advisory Group on Immunisation (ATAGI) confirming the importance and safety of administering the hepatitis B vaccine at birth. Responding to …
Hepatitis Australia, ASHM and the Australian Technical Group on Immunisation (ATAGI) are urging Australians to maintain routine hepatitis B vaccinations for newborns following the alarming news that the advisory panel …
HepSA Library October acquisition highlights: HBV surveillance, managing hep B, hep D advances, and more…
Involvement in a clinical trial may provide access to new treatments and provide participants with a higher level of clinical care, which many people with fatty liver find beneficial.
November 2025
